Cost of New Cholesterol Drugs Unsustainable, Says Study
Tuesday, August 16, 2016 - 14:21
in Health & Medicine
A new UC San Francisco-led study using computer models of cardiovascular disease in American adults concludes that the price of a promising new class of cholesterol-lowering drugs called PCSK9 inhibitors would need to be reduced by up to 70 percent to be cost-effective in the United States using commonly accepted standards. “If all eligible US […]